Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 9, 2013

Hamilton Takes Over Fogale’s Biotech Sensor Business

  • Hamilton signed an agreement to acquire the biotech sensors business of the French company Fogale Nanotech. With this deal Hamilton says it becomes the only sensor manufacturer offering all valuable parameters for the online monitoring of bioprocesses, i.e., pH, dissolved oxygen and biomass.

    According to Hamilton, the Fogale biomass sensor uses the dielectric properties of living cells, which has the advantage of measuring only viable cell density. “Unlike optical techniques, the system is not sensitive to gas bubbles, microcarriers, cell debris, and other particles in suspension,” explained Jörg Pochert, vp laboratory and sensors of Hamilton.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »